Federal Circuit Rules For Apotex In Paxil Patent Suit
In a blow to U.K. drug maker GlaxoSmithKline, the U.S. Court of Appeals for the Federal Circuit has rejected a key claim for the U.S. patent covering Paxil (paroxetine hydrochloride), the...To view the full article, register now.
Already a subscriber? Click here to view full article